Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

RFK Jr. acts to ease access to unproven peptides despite opposition from FDA scientists

The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific…

DO
By Daniel Okafor · Regulatory Correspondent
Oct 28 14:09 ETSource: CNN

From the source

RFK Jr. acts to ease access to unproven peptides despite opposition from FDA scientists

The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.

Read at cnn.com
PeptiPrescribed peptides from $99/moSee all →